Antibodies Global Market Report 2024

Antibodies Global Market Report 2024 – By Product Type (Monoclonal Antibodies, Polyclonal Antibodies, Antibody Drug Complexes), By Disease Indication (Cardiovascular Diseases, Central Nervous System (CNS) Disorders, Cancer, Autoimmune Disorders, Other Indications), By End User (Hospitals, Long Term Care Facilities, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Name: Antibodies Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Antibodies Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : November 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Antibodies Market Definition

Antibodies are proteins produced by the immune system in response to foreign substances, such as bacteria or viruses. They specifically recognize and bind to antigens, which are unique molecules on the surface of these invaders. This binding helps neutralize the pathogen or marks it for destruction by other immune cells. Antibodies are a crucial component of the body's adaptive immune response. Each antibody is specific to a particular antigen.

The main types of products in the antibodies market are monoclonal antibodies, Polyclonal Antibodies, and antibody drug complexes. Monoclonal antibodies refer to laboratory-produced molecules that are designed to bind specifically to certain proteins or antigens in the body. The various disease indications include cardiovascular diseases, central nervous system (CNS) disorders, cancer, autoimmune disorders, and others, and several end users including hospitals, long term care facilities, research institutes, and others.

Antibodies Market Segmentation

The antibodies market covered in this report is segmented –

1) By Product Type: Monoclonal Antibodies, Polyclonal Antibodies, Antibody Drug Complexes

2) By Disease Indication: Cardiovascular Diseases, Central Nervous System (CNS) Disorders, Cancer, Autoimmune Disorders, Other Indications

3) By End User: Hospitals, Long Term Care Facilities, Research Institutes, Other End Users

Global Antibodies Market Size 2023 to 2028: Graph

Antibodies Market Size 2024 And Growth Rate

The antibodies market size has grown rapidly in recent years. It will grow from $249.13 billion in 2023 to $286.81 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to rise in prevalence of chronic diseases, growth in number of clinical trials, expansion of therapeutic areas, growth in awareness of personalized medicine, and rise in diagnostic applications.

Antibodies Market Growth Forecast

The antibodies market size is expected to see rapid growth in the next few years. It will grow to $504.99 billion in 2028 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to increasing cancer research, growing immunotherapy applications, increasing use of monoclonal antibodies, rising number of clinical trials, and increasing adoption of precision medicine. Major trends in the forecast period include the implementation of advanced biomanufacturing technologies, advancements in antibody engineering, integration of high throughput screening methods, implementation of next-generation sequencing technologies, and implementation of novel delivery systems.

Book your 30 minutes free consultation with our research experts

Antibodies Market Driver: Growing Autoimmune Disease Rates Fuel Expansion In Antibodies Market

The rising prevalence of autoimmune diseases is expected to propel the growth of the antibodies market going forward. Autoimmune diseases refer to conditions where the immune system erroneously targets and damages its own tissues, including disorders such as rheumatoid arthritis, lupus, and multiple sclerosis. The growing rate of autoimmune diseases is attributed to environmental factors, genetic susceptibility, and alterations in lifestyle. Antibodies target and neutralize specific immune cells or inflammatory molecules that mistakenly attack the body's own tissues, thereby reducing inflammation and alleviating symptoms. For instance, in May 2024, according to the Multiple Sclerosis International Federation, a UK-based non-profit organization, the global number of people with multiple sclerosis increased from 2.8 million in 2020 to 2.9 million in 2023. Therefore, the rising prevalence of autoimmune diseases is driving the antibodies market.

Global Antibodies Market Major Players

Major companies operating in the antibodies market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb Company, Novartis AG, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Alexion Pharmaceuticals Inc., Incyte Corporation, Kyowa Kirin Co Ltd., Ultragenyx Pharmaceutical Inc., Xencor Inc., MacroGenics Inc., ImmunoGen Inc., Sorrento Therapeutics Inc., Beam Therapeutics Inc., SAB Biotherapeutics Inc., bluebird bio Inc., Iovance Biotherapeutics Inc.

Global Antibodies Market Trend: CelSelect Validated Antibodies Enhance Precision In Cancer Research And Diagnostics

Major companies operating in the antibodies market are developing validated antibodies to enhance accuracy and ensure consistent results in diagnostics and therapeutics. Validated antibodies are antibodies that have been tested and confirmed for accuracy and specificity in detecting target proteins, enhancing the credibility of research results, and ensuring the quality and effectiveness of antibody-based products. For instance, in March 2024, Bio-Rad Laboratories, a US-based life science research and clinical diagnostics manufacturing company, launched Celselect slides validated antibodies for rare cell and circulating tumor cell (CTC) enumeration, enhancing the study of tumor heterogeneity and disease progression. These antibodies, compatible with Bio-Rad’s Celselect Slides Enumeration Stain Kits, enable precise CTC detection and mark a significant advancement supporting advanced cancer research and diagnostics.

Antibodies Market Merger And Acquisition: Johnson & Johnson Acquires Proteologix To Boost Immunology Portfolio

In June 2024, Johnson & Johnson Services Inc., a US-based pharmaceutical and medical device manufacturing company, acquired Proteologix Inc. for $850 million. Through this acquisition, Johnson & Johnson aims to strategically enhance its development of innovative treatments for immune-mediated diseases by gaining Proteologix's advanced bispecific antibodies, aligning with its goal to advance its immunology portfolio with effective, optimized therapies for conditions such as atopic dermatitis and asthma. Proteologix Inc. is a US-based provider of antibodies.

Regional Insights For The Global Antibodies Market

North America was the largest region in the antibodies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibodies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antibodies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antibodies market consists of sales of recombinant antibodies, antibody-based assays, bispecific antibodies, single domain antibodies, humanized antibodies, and diagnostic kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The antibodies market research report is one of a series of new reports from The Business Research Company that provides antibodies market statistics, including the antibodies industry global market size, regional shares, competitors with antibodies market share, detailed antibodies market segments, market trends, and opportunities, and any further data you may need to thrive in the antibodies industry. These antibodies market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Antibodies Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2024	$ 1053.32 Billion
Revenue Forecast In 2033	$ 1499 Billion
Growth Rate	CAGR of 9.20% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Product Type: Monoclonal Antibodies, Polyclonal Antibodies, Antibody Drug Complexes 2) By Disease Indication: Cardiovascular Diseases, Central Nervous System (CNS) Disorders, Cancer, Autoimmune Disorders, Other Indications 3) By End User: Hospitals, Long Term Care Facilities, Research Institutes, Other End Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb Company, Novartis AG, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Alexion Pharmaceuticals Inc., Incyte Corporation, Kyowa Kirin Co Ltd, Ultragenyx Pharmaceutical Inc, Xencor Inc., MacroGenics Inc., ImmunoGen Inc., Sorrento Therapeutics Inc., Beam Therapeutics Inc., SAB Biotherapeutics Inc., bluebird bio Inc., Iovance Biotherapeutics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Antibodies Market Characteristics

3. Antibodies Market Trends And Strategies

4. Antibodies Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Antibodies Market Size and Growth

5.1. Global Antibodies Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Antibodies Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Antibodies Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Antibodies Market Segmentation

6.1. Global Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Monoclonal Antibodies

Polyclonal Antibodies

Antibody Drug Complexes

6.2. Global Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Cardiovascular Diseases

Central Nervous System (CNS) Disorders

Cancer

Autoimmune Disorders

Other Indications

6.3. Global Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospitals

Long Term Care Facilities

Research Institutes

Other End Users

7. Antibodies Market Regional And Country Analysis

7.1. Global Antibodies Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Antibodies Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Antibodies Market

8.1. Asia-Pacific Antibodies Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Antibodies Market

9.1. China Antibodies Market Overview

9.2. China Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Antibodies Market

10.1. India Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Antibodies Market

11.1. Japan Antibodies Market Overview

11.2. Japan Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Antibodies Market

12.1. Australia Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Antibodies Market

13.1. Indonesia Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Antibodies Market

14.1. South Korea Antibodies Market Overview

14.2. South Korea Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Antibodies Market

15.1. Western Europe Antibodies Market Overview

15.2. Western Europe Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Antibodies Market

16.1. UK Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Antibodies Market

17.1. Germany Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Antibodies Market

18.1. France Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.2. France Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.3. France Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Antibodies Market

19.1. Italy Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.2. Italy Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.3. Italy Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Antibodies Market

20.1. Spain Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.2. Spain Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.3. Spain Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Antibodies Market

21.1. Eastern Europe Antibodies Market Overview

21.2. Eastern Europe Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Antibodies Market

22.1. Russia Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Antibodies Market

23.1. North America Antibodies Market Overview

23.2. North America Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Antibodies Market

24.1. USA Antibodies Market Overview

24.2. USA Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Antibodies Market

25.1. Canada Antibodies Market Overview

25.2. Canada Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Antibodies Market

26.1. South America Antibodies Market Overview

26.2. South America Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Antibodies Market

27.1. Brazil Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Antibodies Market

28.1. Middle East Antibodies Market Overview

28.2. Middle East Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Antibodies Market

29.1. Africa Antibodies Market Overview

29.2. Africa Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Antibodies Market Competitive Landscape And Company Profiles

30.1. Antibodies Market Competitive Landscape

30.2. Antibodies Market Company Profiles

30.2.1. Pfizer Inc.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Johnson & Johnson Services Inc.

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. F. Hoffmann-La Roche Ltd.

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Merck & Co Inc.

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. AbbVie Inc.

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Antibodies Market Other Major And Innovative Companies

31.1. Sanofi S.A.

31.2. Bristol Myers Squibb Company

31.3. Novartis AG

31.4. GSK plc

31.5. Takeda Pharmaceutical Company Limited

31.6. Eli Lilly and Company

31.7. Amgen Inc.

31.8. Regeneron Pharmaceuticals Inc.

31.9. Biogen Inc.

31.10. Alexion Pharmaceuticals Inc.

31.11. Incyte Corporation

31.12. Kyowa Kirin Co Ltd

31.13. Ultragenyx Pharmaceutical Inc

31.14. Xencor Inc.

31.15. MacroGenics Inc.

32. Global Antibodies Market Competitive Benchmarking

33. Global Antibodies Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Antibodies Market

35. Antibodies Market Future Outlook and Potential Analysis

35.1 Antibodies Market In 2028 - Countries Offering Most New Opportunities

35.2 Antibodies Market In 2028 - Segments Offering Most New Opportunities

35.3 Antibodies Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Figure 1:

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Figure 3: Global Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 4: Global Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 5: Global Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 6: Global Antibodies Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 7: Global Antibodies Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 8: Asia-Pacific, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 9: Asia-Pacific, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 10: Asia-Pacific, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 11: China, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 12: China, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 13: China, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 14: India, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 15: India, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 16: India, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 17: Japan, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 18: Japan, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 19: Japan, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 20: Australia, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 21: Australia, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 22: Australia, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 23: Indonesia, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 24: Indonesia, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 25: Indonesia, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 26: South Korea, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 27: South Korea, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 28: South Korea, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 29: Western Europe, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 30: Western Europe, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 31: Western Europe, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 32: UK, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 33: UK, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 34: UK, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 35: Germany, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 36: Germany, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 37: Germany, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 38: France, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 39: France, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 40: France, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 41: Italy, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 42: Italy, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 43: Italy, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 44: Spain, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 45: Spain, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 46: Spain, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 47: Eastern Europe, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 48: Eastern Europe, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 49: Eastern Europe, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 50: Russia, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 51: Russia, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 52: Russia, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 53: North America, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 54: North America, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 55: North America, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 56: USA, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 57: USA, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 58: USA, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 59: Canada, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 60: Canada, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 61: Canada, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 62: South America, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 63: South America, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 64: South America, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 65: Brazil, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 66: Brazil, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 67: Brazil, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 68: Middle East, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 69: Middle East, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 70: Middle East, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 71: Africa, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 72: Africa, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 73: Africa, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 74: Pfizer Inc. Financial Performance
Figure 75: Johnson & Johnson Services Inc. Financial Performance
Figure 76: F. Hoffmann-La Roche Ltd. Financial Performance
Figure 77: Merck & Co Inc. Financial Performance
Figure 78: AbbVie Inc. Financial Performance

List Of Figures

Table 1:

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 6: Global Antibodies Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 7: Global Antibodies Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 8: Asia-Pacific, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 9: Asia-Pacific, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 10: Asia-Pacific, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 11: China, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 12: China, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 13: China, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 14: India, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 15: India, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 16: India, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 17: Japan, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 18: Japan, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 19: Japan, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 20: Australia, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 21: Australia, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 22: Australia, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 23: Indonesia, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 24: Indonesia, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 25: Indonesia, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 26: South Korea, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 27: South Korea, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 28: South Korea, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 29: Western Europe, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 30: Western Europe, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 31: Western Europe, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 32: UK, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 33: UK, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 34: UK, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 35: Germany, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 36: Germany, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 37: Germany, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 38: France, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 39: France, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 40: France, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 41: Italy, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 42: Italy, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 43: Italy, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 44: Spain, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 45: Spain, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 46: Spain, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 47: Eastern Europe, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 48: Eastern Europe, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 49: Eastern Europe, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 50: Russia, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 51: Russia, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 52: Russia, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 53: North America, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 54: North America, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 55: North America, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 56: USA, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 57: USA, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 58: USA, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 59: Canada, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 60: Canada, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 61: Canada, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 62: South America, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 63: South America, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 64: South America, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 65: Brazil, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 66: Brazil, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 67: Brazil, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 68: Middle East, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 69: Middle East, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 70: Middle East, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 71: Africa, Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 72: Africa, Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 73: Africa, Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 74: Pfizer Inc. Financial Performance
Table 75: Johnson & Johnson Services Inc. Financial Performance
Table 76: F. Hoffmann-La Roche Ltd. Financial Performance
Table 77: Merck & Co Inc. Financial Performance
Table 78: AbbVie Inc. Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

Conjugated Monoclonal Antibodies Global Market Report 2024 – By Drugs (Adcetris, Kadcyla), By Technology (Cleavable Linker, Non-cleavable Linker), By Application (Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Arthritis Monoclonal Antibodies Global Market Report 2024 – By Drug (Remicade, Humira, Enbrel, Rituxan, Orencia, Actemra, Simponi, Cimzia, Remsima), By Application (Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Other Applications), By End-Use (Hospitals, Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Breast Cancer Monoclonal Antibodies Global Market Report 2024 – By Product (Naked Mabs, Conjugated Mabs), By Treatment (Chemotherapy, Surgery & Radiation Therapy, Targeted Therapy, Biologic Therapy, Hormone Therapy), By End-User (Hospitals, Retail Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Monoclonal Antibodies (MAs) Global Market Report 2024 – By Source (Murine, Chimeric, Humanized, Human), By Application (Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAs), Neuropharmacological, Cardiovascular And Cerebrovascular, Other Applications), By End Users (Hospitals, Private Clinics, Research Institute) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Biosimilar Monoclonal Antibodies Global Market Report 2024 – By Type (Synthetic Chemicals, Biopharmaceuticals, Other Types), By Compound (Infliximab, Rituximab, Abciximab, Trastuzumab, Adalimumab, Bevacizumab), By Application (Chronic & Autoimmune Diseases, Oncology, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Neuroscience Antibodies & Assays Global Market Report 2024 – By Product (Consumables, Instruments ), By Technology (Molecular Diagnostics, Clinical Chemistry, Immunoassays Or Immunochemistry, Others Technologies ), By Application (In Vitro Diagnostics, Research, Drug Discovery ), By End User (Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Research Antibodies and Reagents Global Market Report 2024 – By Technology (Western Blot, Immunofluorescence, Immunohistochemistry, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (Elisa), Others), By Application (Proteomics, Genomics, Other Applications), By End User (Pharmaceutical & Biotechnology Industry, Academic & Research Institutes, Contract Research Organizations (CROs)) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cancer Monoclonal Antibodies Global Market Report 2024 – By Monoclonal Antibody Therapies (Avastin, Herceptin, Keytruda, Opdivo, Darzalex, Perjeta, Others), By Application (Breast Cancer, Blood Cancer, Lung Cancer, Brain Tumor, Colorectal Cancer, Cervical Cancer, Gastric Cancer, Others), By End-User (Hospitals, Research Laboratories, Others) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the antibodies market?

How will the antibodies market drivers and restraints affect the antibodies market dynamics? What forces will shape the antibodies industry going forward?

The antibodies market major growth driver - Growing Autoimmune Disease Rates Fuel Expansion In Antibodies Market. For further insights on the antibodies market, request a sample here

What is the forecast market size or the forecast market value of the antibodies market?

The antibodies market size has grown rapidly in recent years. It will grow from $249.13 billion in 2023 to $286.81 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to rise in prevalence of chronic diseases, growth in number of clinical trials, expansion of therapeutic areas, growth in awareness of personalized medicine, and rise in diagnostic applications. The antibodies market size is expected to see rapid growth in the next few years. It will grow to $504.99 billion in 2028 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to increasing cancer research, growing immunotherapy applications, increasing use of monoclonal antibodies, rising number of clinical trials, and increasing adoption of precision medicine. Major trends in the forecast period include the implementation of advanced biomanufacturing technologies, advancements in antibody engineering, integration of high throughput screening methods, implementation of next-generation sequencing technologies, and implementation of novel delivery systems. For further insights on the antibodies market, request a sample here

How is the antibodies market segmented?

The antibodies market is segmented
1) By Product Type: Monoclonal Antibodies, Polyclonal Antibodies, Antibody Drug Complexes
2) By Disease Indication: Cardiovascular Diseases, Central Nervous System (CNS) Disorders, Cancer, Autoimmune Disorders, Other Indications
3) By End User: Hospitals, Long Term Care Facilities, Research Institutes, Other End Users For further insights on the antibodies market, request a sample here

Which region has the largest share of the antibodies market? What are the other regions covered in the report?

North America was the largest region in the antibodies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibodies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the antibodies market, request a sample here.

Who are the major players in the antibodies market?

What are the key trends in the antibodies market?

Major trend in the antibodies market - CelSelect Validated Antibodies Enhance Precision In Cancer Research And Diagnostics. For further insights on the antibodies market, request a sample here.

What are the major opportunities in the antibodies market? What are the strategies for the antibodies market?

For detailed insights on the major opportunities and strategies in the antibodies market, request a sample here.

How does the antibodies market relate to the overall economy and other similar markets?

For detailed insights on antibodies market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the antibodies industry?

For detailed insights on the mergers and acquisitions in the antibodies industry, request a sample here.

What are the key dynamics influencing the antibodies market growth? SWOT analysis of the antibodies market.

For detailed insights on the key dynamics influencing the antibodies market growth and SWOT analysis of the antibodies industry, request a sample here.